KAVI - Institute of Clinical Research

Featured News

KAVI-ICR and India’s NCBS collaborate to enhance vaccine development

The team from NCBS led by Lt. General Velu Nair, met the Vice-Chancellor, Prof. Peter Mbithi when they paid a courtesy call on him on March 21, 2018.

The University of Nairobi’s KAVI-Institute of Clinical Research (KAVI-ICR) and the National Centre for Biological Sciences (NCBS), India, have established and initiated a collaboration to spearhead vaccine development through enhanced technology. According to the Director, KAVI-ICR, Prof. Omu Anzala, the partnership will see the team expand metagenomics sequencing from selected target groups in India and Africa and inform the newly emerging pathogens such as Chikungunya and Dengue in their virology, pathology, the point of care diagnostics and vaccine designs.

Read More...

NCBS in Collaboration with KAVI-ICR Vaccine & Technology Platform

Initiation of the Collaboration between NCBS (India) and KAVI-ICR (University Of Nairobi, Kenya) while training University of Nairobi staff on flow cytometry 19th to 23rd March 2018.

National Centre for Biological Sciences (NCBS)-India and KAVI-Institute of Clinical Research (KAVI-ICR)

NCBS (India) and KAVI-ICR (University of Nairobi, Kenya) have established and initiated a collaboration to spearhead the following;

• Expand metagenomics sequencing from selected target groups in India and Africa and inform the newly emerging pathogens (Chikungunya, Dengue & others) in their virology, pathology, a point of care diagnostics and vaccine designs
• Facilitate vaccine manufacture of existing vaccines in Africa
• Facilitate the Dengue programs using some of the existing facilities such as the animal house, screening program, imaging, flow units, and genomics.
• Enabling the NCBS and KAVI-ICR off campus and hospital/community engagements with an evolving data science perspective
• Exploring the additional use of novel cutting-edge technologies that NCBS is currently using such as next-generation sequencing technologies to evolve therapeutic vaccines
• Joint development of infrastructure and research
• Joint teaching arrangements for postgraduate programmes
• Joint supervision of Postgraduate projects
• Student and faculty, exchange
• Joint application for funding including donor funds, research grants, contributions subscriptions
• Participation in joint academic seminars, training, meetings including participation with other collaborators
• Any other collaborative efforts as may be determined from time to time.
• Operational guidelines both academic and budgetary for each activity under the MOU shall be set down in a specific letter of agreement.